ArticleJournal of medicinal chemistry2020

Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology.

Marialuisa Moccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.